Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial

Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial

© 2020 Lippincott Williams and Wilkins. All rights reserved. Background: Vaccination against seasonal influenza is recommended for all children with a history of medical conditions placing them at increased risk of influenza-associated complications. The immunogenicity and efficacy of conventional i...

Full description

Saved in:
Bibliographic Details
Main Authors: Susanna Esposito, John Fling, Kulkanya Chokephaibulkit, Marianne De Bruijn, Janine Oberye, Bin Zhang, Jeanique Vossen, Esther Heijnen, Igor Smolenov
Other Authors: Janssen Vaccines & Prevention B.V.
Format: Article
Published: 2020
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/58320
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/58320

Similar Items